Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Berek

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|October 13, 2006
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 womenMallory Zhang, Michael K Cheung, Jacob Y Shin, et al.
Nature Communications|August 16, 2012
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damageYoung Min Chung, See-Hyoung Park, Wen-Bin Tsai, et al.
Obstetrics and Gynecology|March 3, 2007
Prognostic factors for uterine cancer in reproductive-aged womenNita Karnik Lee, Michael K Cheung, Jacob Y Shin, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deathsStefanie M Ueda, Daniel S Kapp, Michael K Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancerJonathan S Berek, Peyton T Taylor, Alan Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Allison W Kurian, Kevin C Ward, Paul Abrahamse, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancerJohn K Chan, Daniel S Kapp, Michael K Cheung, et al.
Sleep Medicine|August 25, 2022
Symptoms and survivorship needs differences between "good sleepers" and "bad sleepers" in survivors of breast and gynecologic cancersOxana Palesh, Leah T Tolby, Elisa N Hofmeister, et al.
Cancer|May 16, 2007
Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patientsJohn K Chan, Renata Urban, Michael K Cheung, et al.
Obstetrics and Gynecology|June 2, 2007
Influence of the gynecologic oncologist on the survival of ovarian cancer patientsJohn K Chan, Daniel S Kapp, Jacob Y Shin, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|October 13, 2006
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 womenMallory Zhang, Michael K Cheung, Jacob Y Shin, et al.
Nature Communications|August 16, 2012
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damageYoung Min Chung, See-Hyoung Park, Wen-Bin Tsai, et al.
Obstetrics and Gynecology|March 3, 2007
Prognostic factors for uterine cancer in reproductive-aged womenNita Karnik Lee, Michael K Cheung, Jacob Y Shin, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deathsStefanie M Ueda, Daniel S Kapp, Michael K Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancerJonathan S Berek, Peyton T Taylor, Alan Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019Allison W Kurian, Kevin C Ward, Paul Abrahamse, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancerJohn K Chan, Daniel S Kapp, Michael K Cheung, et al.
Sleep Medicine|August 25, 2022
Symptoms and survivorship needs differences between "good sleepers" and "bad sleepers" in survivors of breast and gynecologic cancersOxana Palesh, Leah T Tolby, Elisa N Hofmeister, et al.
Cancer|May 16, 2007
Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patientsJohn K Chan, Renata Urban, Michael K Cheung, et al.
Obstetrics and Gynecology|June 2, 2007
Influence of the gynecologic oncologist on the survival of ovarian cancer patientsJohn K Chan, Daniel S Kapp, Jacob Y Shin, et al.
Pageof 14